We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Albion Technology & General Vct Plc | LSE:AATG | London | Ordinary Share | GB0005581672 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 69.00 | 67.50 | 70.50 | 69.00 | 69.00 | 69.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | -2.85M | -6.3M | -0.0354 | -19.49 | 122.68M |
TIDMAATG Issue of Equity and Total Voting Rights ALBION TECHNOLOGY & GENERAL VCT PLC LEI Code 213800TKJUY376H3KN16 The first allotment of new ordinary shares of nominal value 1 penny per share in Albion Technology & General VCT PLC (the "Company") under the Albion VCTs Prospectus Top Up Offers 2018/19 (the "Offers"), (which was launched on 7 January 2019) took place on 1 April 2019, for the 2018/2019 tax year. Pursuant to the Prospectus dated 7 January 2019, the Company offered a 1% discount on issue costs to existing shareholders and 0.5% discount on issue costs to new subscribers. These early bird discounts were available to investors subscribing for new shares for the first GBP10m by 2 p.m. on 28 February 2019, across the six VCTs participating in the Offers. The cost of these discounts is being borne by the Manager, Albion Capital Group LLP. The issue pricing of the new shares has been calculated to avoid any capital dilution to existing shareholders who do not participate in the Offers. The Company has received valid applications for 1,188,131 new ordinary shares which will be allotted at an issue price of 78.6 pence per share from existing shareholders and 287,073 new ordinary shares allotted at an issue price of 79.0 pence per share for new subscribers, both of which qualified for early bird discounts. A further 6,429,303 new ordinary shares will be allotted at an issue price of 79.4 pence per share (which did not qualify for the early bird discounts). The total net proceeds receivable by the Company for these allotments is approximately GBP6,120,000. Application has been made to the Financial Conduct Authority for 7,904,507 new ordinary shares to be admitted to the Official List, to the London Stock Exchange and for the new ordinary shares to be admitted to trading on the London Stock Exchange's market for listed securities. The new ordinary shares rank pari passu with the existing shares in issue. It is expected that admission will become effective, and that dealings in the new shares will commence on or before 8.00 a.m. on 4 April 2019. The Offers constitute separate offers made by each of the Albion VCT's. As at 1 April 2019, the amount raised in total across the Albion VCTs under the Offers was GBP44m (of which GBP2.5m relates to tax year 2019/2020) and the Offers will remain open until 2 p.m. on 30 September 2019 (unless fully subscribed before this date). Following this allotment and in conformity with the provisions of DTR 5.6, we make the following notifications in connection with the issued share capital of the Company: The Company's capital as at 1 April 2019 consists of 126,616,096 ordinary shares with a nominal value of 1 penny each. The Company holds 16,511,470 ordinary shares in Treasury. The total number of voting rights in the Company is 110,104,626, which may be used by shareholders and other persons as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules. For further information, please contact: Albion Capital Group LLP Company Secretary 020 7601 1850 2 April 2019
(END) Dow Jones Newswires
April 02, 2019 06:47 ET (10:47 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Albion Technology & Gene... Chart |
1 Month Albion Technology & Gene... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions